Astellas Pharma Inc. (ALPMY)
PNK: ALPMY
· Real-Time Price · USD
9.25
-0.19 (-2.01%)
At close: May 13, 2025, 3:59 PM
Astellas Pharma Revenue
Astellas Pharma reported an annual revenue of $1,603.7B, reflecting a 5.6% growth. For the quarter ending June 30, 2024, Astellas Pharma generated $473.12B in revenue.
Revenue (ttm)
$1,603.7B
Revenue Growth
5.6%
Price / Sales Ratio
1.83
Revenue / Employee
$108.69M
Employees
14,754
Market Cap
16.56B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|